Corneal Endothelial Dystrophy Market Analysis: Key Trends, Share, Growth Drivers, And Forecast 2025-2034
The Business Research Company
Corneal Endothelial Dystrophy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, March 25, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
The corneal endothelial dystrophy global market report reveals a dynamic and growing market that is predicted to surge from a worth of $170.96 billion in 2024 to $185.38 billion in 2025. This rapid market expansion represents a compound annual growth rate CAGR of 8.4% and can be credited to a variety of contributory factors such as escalating healthcare expenditures, a rise in the prevalence of endothelial corneal dystrophy, a burgeoning aging population, increasing pervasiveness of eye diseases, and surge in prevalence of corneal disorders.
What will be the future growth of the corneal endothelial dystrophy market?
The promising future of the corneal endothelial dystrophy market is confirmed with expectations of strong growth in the subsequent years. The market is poised to expand to $252.88 billion by 2029 at a compound annual growth rate CAGR of 8.1%. The escalation during the forecast period is partly attributable to a rise in corneal blindness in emerging economies, accentuated awareness about eye care, an increased demand for corneal transplantation, boosted healthcare infrastructure, and an upswing in the prevalence of chronic disorders. Advanced therapeutic developments including advancements in regenerative therapies, medical technology, diagnostic techniques, ophthalmic lasers, and other technologies are expected to represent significant drivers of this market growth into the foreseeable future.
Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample_request?id=21158&type=smp
What are the key drivers pushing the corneal endothelial dystrophy market forward?
A key market driver promoting growth is the growing demand for corneal transplantation. As a surgical procedure where a damaged or diseased cornea is substituted with a healthy donor cornea to restore vision and augment eye health, corneal transplants are becoming increasingly popular. Rising prevalence of corneal diseases coupled with advancements in surgical techniques and elevated organ donation rates contribute to this growth. As an example, in 2023, the Eye Bank Association of America reported an increase in keratoplasty procedures a form of corneal transplantation of 2.7%, from 49,597 in 2022 to 50,925 in 2023.
Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/corneal-endothelial-dystrophy-global-market-report
Who are the key industry players in the corneal endothelial dystrophy market?
The corneal endothelial dystrophy market is shaped by offerings from key industry players including F. Hoffmann-La Roche AG, Abbvie Allergan plc, Teva Pharmaceutical Industries Ltd, Fujifilm Holdings Corporation, Alcon Inc., Bausch Health+Lomb, Santen Pharmaceutical Co., Ltd., AGC Biologics Inc, Lumenis Ltd, Aurion Biotech Inc, Carl Zeiss Meditec AG, Keeler Limited, Kowa Company Ltd., ProQR Therapeutics N.V., Cellusion Inc., OptoTech GmbH, ActualEyes Inc., Arctic Vision Inc., Aurion Biotech LLC, and Emmecell S.R.L.
What are some of the emerging trends in the corneal endothelial dystrophy market?
In a bid to address existing medical needs and provide minimally invasive treatment options that improve patient outcomes, these key players are committed to the development of innovative treatments such as allogeneic cell therapy. For instance, in September 2024, Aurion Biotech Inc. launched Vyznova neltependocel in Japan for the treatment of bullous keratopathy, a corneal endothelial disease. This cell therapy is paving new ground by offering a less invasive alternative to corneal transplants, essentially harnessing lab-grown corneal endothelial cells to address the shortage of donor corneas.
How is the corneal endothelial dystrophy market segmented?
The corneal endothelial dystrophy market can be segmented by:
1 Treatment: Phototherapeutic Keratectomy, Amniotic Membrane Transplants, Anterior Stromal Puncture, Conjunctival Flaps
2 Disease Type: Congenital Hereditary Endothelial Dystrophy 1, Congenital Hereditary Endothelial Dystrophy 2, Posterior Polymorphous Corneal Dystrophy, Fuchs Endothelial Corneal Dystrophy
3 Diagnosis: Cornea Examination And Grading, Corneal Tomography, Corneal Pachymetry, Corneal Cell Count
4 End-User: Hospitals, Clinics, Other End Users
Which region dominates the corneal endothelial dystrophy market?
Regionally, North America represented the largest market share in 2024, with Asia-Pacific anticipated to be the fastest-growing region in the forthcoming years.
Browse For More Similar Reports-
Corneal Implants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/corneal-implants-global-market-report
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/vascular-endothelial-growth-factor-inhibitors-global-market-report
Anti-Vascular Endothelial Growth Factor Therapeutics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/anti-vascular-endothelial-growth-factor-therapeutics-global-market-report
About The Business Research Company:
The Business Research Company boasts a repository of over 15000+ reports spanning 27 industries and 60+ geographies. It prides itself on comprehensive, data-rich research and insights. Armed with 1.5 million datasets, in-depth secondary research, and unique insights from industry leaders, it provides valuable data that helps you to stay ahead in the game.
Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: info@tbrc.info
Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Submit your press release